PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Chart, page-2167

  1. 765 Posts.
    lightbulb Created with Sketch. 216
    Although the outstanding issue appears fairly innocuous, the fact PAR weren’t able to address it in the 30 days seems to have cost plenty. No hurry for anyone to invest, short term investors missed the calculated risk of expecting a go ahead so will sell, some long term holders a little worn out and a broker downgrade all helping any shorter go harder for the near term. All compounding the current state. There will be a short term bottom (probably see it on a chart) and hopefully within the next two months it turns the corner. Management doesn’t escape some criticism due to missing momentum created by getting it right the first time. Good luck to them getting what is a rather large process done successfully. Tks for those regulars posting some very informative stuff and GLTA It’s usually a marathon in this sector.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $187.1K 755.0K

Buyers (Bids)

No. Vol. Price($)
2 47906 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 13363 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.